Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
Published on November 18, 2017, at NEJM.org.
Monogenic Diseases of DNA Repair
N Engl J Med 2017;377:1868-76.
Selective Inhibition Mechanism of RVX-208
Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: insight from microsecond molecular dynamics simulations.
Atezolizumab in Combination with Bevacizumab
Atezolizumab in Combination with Bevacizumab in Untreated mRCC: Updated Analysis of IMmotion150 Study [LBA39] Powles T, et al.